Evaluation of Patients With Heart Disease Not Eligible for Research Protocols
NCT ID: NCT00001458
Last Updated: 2021-03-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
7829 participants
OBSERVATIONAL
1995-01-01
2020-07-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Clinical research continues to become more focused on specific diseases and the signs and symptoms of diseases in specific groups of people and patients.
This study is designed to permit inpatient evaluation and care of patients with heart disease who do not qualify to participate in research studies being conducted by the Cardiology Branch of the National Heart, Lung, and Blood Institute (NHLBI). These patients are valuable to the Cardiology Branch of the NHLBI because they help to improve training and experience of its researchers.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Outpatient Evaluation of Patients With Known or Suspected Heart Disease
NCT00001400
Evaluation of Patients With Known or Suspected Heart Disease
NCT00001313
Clinical Outcomes of Patients With Coronary Artery Disease
NCT06216847
Pilot Study to Assess the Proteome in Human Atrial Tissue
NCT00591903
Analysis of Heart Muscle Function Following Exercise in Patients With Heart Disease
NCT00001528
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cardiovascular
subjects with cardiovascular symptoms or known disease.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Coronary artery disease with effort or rest angina or inducible myocardial ischemia as determined by noninvasive testing.
Valvular heart disease.
Cardiomyopathies, including restrictive, congestive, and hypertrophic phenotypes.
Peripheral-artery disease of upper or lower extremities, with intermittent pain with activity (e.g. claudication) or limb-threatening ischemia.
Renovascular disease with uncontrolled hypertension, intermittent pulmonary edema, or evidence of ischemic nephropathy.
Congenital heart disease, with communications between chambers or major vessels
Heart surgery patients treated at the Clinical Center prior to closure of the Heart Surgery Branch in 1990
Exclusion Criteria
Inability of patient, parent or legal guardian to provide informed consent.
99 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alessandra Brofferio, M.D.
Role: PRINCIPAL_INVESTIGATOR
National Heart, Lung, and Blood Institute (NHLBI)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
NIH Clinical Center Detailed Web Page
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
95-H-0047
Identifier Type: -
Identifier Source: secondary_id
950047
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.